Multicenter study for combined therapy of prednisolone and mizoribine in idiopathic membranous nephropathy with refractory nephrotic syndrome
Not Applicable
- Conditions
- membranous nephropathy with primary steroid resistant nephrotic syndrome
- Registration Number
- JPRN-C000000368
- Lead Sponsor
- Project team for treatment of refractory nephrotic syndrome
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) The subject presents with renal dysfunction (Ccr less than 50mL/min or serum creatinine more than 2mg/dL. 2) The subject previously had serious hypersensitivity to mizoribine. 3) The subject's white blood cells are under 3000/mm3. 4) The subject is currently pregnant, is supposed to be pregnant, plans to become pregnant during the study period, or is nursing. 5) The subject has serious complications. 6) The subject has serious infections by bacteria, fungus or virus. 7) The subject has already been treated with mizoribine at the study commencement. 8) The subject is inappropriate for participation in the study as determined by an investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method